Join Growin Stock Community!

Ascendis pharma a(ASND.US Overview)

US StockHealthcare
No presentation for ASND

ASND AI Insights

ASND Overall Performance

ASND AI Analysis & Strategy

ASND Recent Performance

-0.20%

Ascendis pharma a

-1.38%

Avg of Sector

-1.03%

S&P 500

ASND PowerScanner

ASND Key Information

ASND Valuation Metrics

ASND Earnings Table

ASND Profile

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Price of ASND

ASND FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer